
Our Research and Development Centers
Our global Research & Development (R & D) colleagues are the foundation of our innovative product pipeline. Explore our major R & D centers to discover the latest breakthroughs we’re working on.
Main Research and Development Centers
Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S. and U.K.
Andover, Massachusetts
A 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities
Cambridge, Massachusetts
Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world
Groton, Connecticut
Where nearly every one of our products are, in part, developed
La Jolla, California
With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.
Pearl River, New York
The primary location for our company’s global Vaccine Research and Development work
Sandwich, UK
Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups
St. Louis, MO
A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises

Clinical Trials
Learn more about the process of joining a clinical trial and find a trial near you.
Go to Pfizer Clinical Trials Site DetailsRelated Articles
Science & Innovation
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
Science & Innovation
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.
Purpose & Ideals
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.









